Stock Detail
Sector:
Latest Quote @ Thu Jun 6 04:10:48 (15 min delayed)
| N/A |
N/A |
$0.527 |
-0.012 |
-2.23% |
|
Last Day's Data
| $0.00 |
$0.00 |
$0.00 |
0.00% |
0.00 |
$0.00 |
| $0.00 |
$0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Stock Profile
Neostem, Inc. engages in the collection, processing, and storage of adult stem cells for autologous use in the United States. Its stem cell-banking process primarily involves in the mobilization, cell collection, cell processing, and cryopreservation. The company provides adult stem cells for autologous use in the treatment of cardiac disease, degenerative, autoimmune, neurological, and age-related musculoskeletal disorders, as well as diabetes, breast cancer, and wound healing. It has a strategic alliance with UTEK Corporation. The company was founded in 2002. It was formerly known as Corniche Group Incorporated and changed its name to Phase III Medical, Inc. in 2003. Further, it changed its name to Neostem, Inc. in 2006. Neostem is headquartered in New York, New York.
